# Cefotaxime Sodium Powder, for Solution: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 6
- Latest FDA row update: 08/13/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Hikma Pharmaceuticals USA, Inc. — Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) — FDA availability: Unavailable — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) — FDA availability: Unavailable — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) — FDA availability: Unavailable — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) — FDA availability: Unavailable — updated: 08/13/2026
- SteriMax, Inc. — Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02) — FDA availability: Available — updated: 06/15/2026
- SteriMax, Inc. — Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02) — FDA availability: Available — updated: 06/15/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/cefotaxime-sodium-powder-for-solution)
- [JSON record](https://citefacts.com/shortages/cefotaxime-sodium-powder-for-solution.json)